These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Analgesic effects of the somatostatin sst4 receptor selective agonist J-2156 in acute and chronic pain models. Sándor K; Elekes K; Szabó A; Pintér E; Engström M; Wurster S; Szolcsányi J; Helyes Z Eur J Pharmacol; 2006 Jun; 539(1-2):71-5. PubMed ID: 16697366 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Neurons Expressing the Novel Analgesic Drug Target Somatostatin Receptor 4 in Mouse and Human Brains. Kecskés A; Pohóczky K; Kecskés M; Varga ZV; Kormos V; Szőke É; Henn-Mike N; Fehér M; Kun J; Gyenesei A; Renner É; Palkovits M; Ferdinandy P; Ábrahám IM; Gaszner B; Helyes Z Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096776 [TBL] [Abstract][Full Text] [Related]
7. Analgesic effect of dimethyl trisulfide in mice is mediated by TRPA1 and sst Pozsgai G; Payrits M; Sághy É; Sebestyén-Bátai R; Steen E; Szőke É; Sándor Z; Solymár M; Garami A; Orvos P; Tálosi L; Helyes Z; Pintér E Nitric Oxide; 2017 May; 65():10-21. PubMed ID: 28137611 [TBL] [Abstract][Full Text] [Related]
8. Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia. Szolcsányi J; Bölcskei K; Szabó A; Pintér E; Petho G; Elekes K; Börzsei R; Almási R; Szuts T; Kéri G; Helyes Z Eur J Pharmacol; 2004 Sep; 498(1-3):103-9. PubMed ID: 15363982 [TBL] [Abstract][Full Text] [Related]
9. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain. Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895 [TBL] [Abstract][Full Text] [Related]
10. Discovery of tetrahydropyrido[4,3-d]pyrimidine derivatives for the treatment of neuropathic pain. Sharma M; Deekshith V; Semwal A; Sriram D; Yogeeswari P Bioorg Chem; 2014 Feb; 52():69-76. PubMed ID: 24368171 [TBL] [Abstract][Full Text] [Related]
11. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor. Jarvis MF; Yu H; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Chu K; Kohlhaas K; Cowart M; Lee CH; Stewart AO; Cox BF; Polakowski J; Kowaluk EA Pain; 2002 Mar; 96(1-2):107-18. PubMed ID: 11932067 [TBL] [Abstract][Full Text] [Related]
12. TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice. Vincenzi F; Targa M; Romagnoli R; Merighi S; Gessi S; Baraldi PG; Borea PA; Varani K Neuropharmacology; 2014 Jun; 81():6-14. PubMed ID: 24486382 [TBL] [Abstract][Full Text] [Related]
13. Diosgenin Exerts Analgesic Effects by Antagonizing the Selective Inhibition of Transient Receptor Potential Vanilloid 1 in a Mouse Model of Neuropathic Pain. Rahman MM; Jo HJ; Park CK; Kim YH Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555495 [TBL] [Abstract][Full Text] [Related]
14. Central and peripheral anti-hyperalgesic effects of diosmin in a neuropathic pain model in rats. Carballo-Villalobos AI; González-Trujano ME; Pellicer F; Alvarado-Vásquez N; López-Muñoz FJ Biomed Pharmacother; 2018 Jan; 97():310-320. PubMed ID: 29091880 [TBL] [Abstract][Full Text] [Related]
15. Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents. Helyes Z; Pintér E; Németh J; Sándor K; Elekes K; Szabó A; Pozsgai G; Keszthelyi D; Kereskai L; Engström M; Wurster S; Szolcsányi J Br J Pharmacol; 2006 Oct; 149(4):405-15. PubMed ID: 16953190 [TBL] [Abstract][Full Text] [Related]
16. Ameliorative potential of standardized fruit extract of Pterodon pubescens Benth on neuropathic pain in mice: Evidence for the mechanisms of action. Nucci-Martins C; Martins DF; Nascimento LF; Venzke D; Oliveira AS; Frederico MJ; Silva FR; Brighente IM; Pizzolatti MG; Santos AR J Ethnopharmacol; 2015 Dec; 175():273-86. PubMed ID: 26386380 [TBL] [Abstract][Full Text] [Related]
17. LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain. Lima CK; Silva RM; Lacerda RB; Santos BL; Silva RV; Amaral LS; Quintas LE; Fraga CA; Barreiro EJ; Guimaraes MZ; Miranda AL PLoS One; 2014; 9(6):e99510. PubMed ID: 24941071 [TBL] [Abstract][Full Text] [Related]
18. The analgesic action of larixyl acetate, a potent TRPC6 inhibitor, in rat neuropathic pain model induced by spared nerve injury. Wang J; Zhao M; Jia P; Liu FF; Chen K; Meng FY; Hong JH; Zhang T; Jin XH; Shi J J Neuroinflammation; 2020 Apr; 17(1):118. PubMed ID: 32299452 [TBL] [Abstract][Full Text] [Related]
19. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain. Toyama S; Shimoyama N; Shimoyama M Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630 [TBL] [Abstract][Full Text] [Related]
20. The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice. Paton KF; Kumar N; Crowley RS; Harper JL; Prisinzano TE; Kivell BM Eur J Pain; 2017 Jul; 21(6):1039-1050. PubMed ID: 28158929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]